SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US OTC > Biotechs >

OncoVista Innovative Therapies, Inc. (OVIT)

OVIT RSS Feed
Add OVIT Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/27/2017 12:46:54 PM - Followers: 17 - Board type: Free - Posts Today: 0

OncoVista Innovative Therapies, Inc. (OVIT) 

 

Please see the bottom of the iBox for a contrary view on this stock.

 

http://www.oncovista.com/

 

 

Company Information:

OncoVista Innovative Therapies, Inc.
14785 Omicron Drive
Suite 104
San Antonio,, TX 78245

Phone: 210-677-6000

 

CIK:  0001094847

The latest 10Q can be found here: http://filings.issuerdirect.com/data/1094847/000114420411063209/v240119_10q.pdf

Link to clinical trials register: http://www.clinicaltrials.gov/ct2/results?term=cordycepin 

Neither of the two cordycepin studies registered with clinical.trials.gov has been updated for over two years, which is a breach of registration conditions.

 

 

OncoVista Innovative Therapies, Inc., is a bio-pharmaceutical company that claims to be dedicated to providing innovative, safe and efficacious treatments for cancer through the use of biomarkers in order to extend and improve the quality of life for patients.

Based in San Antonio, Texas, OncoVista was incorporated in 2004 and says it utilizes state-of-the-art drug discovery technologies, innovative clinical development and registration strategies as well as emerging technologies to bring to market new, safe and highly effective anti-cancer drugs. Although no such drugs have yet been brought to market, and the "incubator" behind Onco Vista, Technology Innovations, LLC, has a long and inglorious history of transferring monies from its publicly held spin-offs such as Biophan and Natural Nano into private hands.

 

Management: 

http://www.oncovista.com/index.php?option=com_content&task=view&id=67

 

 

Claims made by Onco Vista regarding its Core Capabilities for Accelerated Drug Development

Lipitek International
Well-equipped research labs for chemical synthesis and biological evaluations; GMP manufacturing suite

UT Health Science Center (Prof. Luduena)
Biological evaluation and testing of new anti-mitotics, including tubulin isotype-specific assays

University of Alberta (Prof. Tuszynski)
Molecular modeling, computer simulation of new molecules, molecule design and in silico screening

AAI Oncology (Paris)
Global oncology-focused clinical Contract Research Organization (CRO)

Cancer Therapy & Research Center (CTRC)/Institute for Drug Development (IDD)
In vitro and in vivo capabilities; Phase I/II clinical trials

Other Local Resources (nothing to do with Onco Vista per se: probably included here to give an impression of referred respectability).
Southwest Oncology Group
Southwest Foundation for Biomedical Research

 

 

 

Press Releases:  
http://www.oncovista.com/index.php?option=com_content&task=view&id=91

http://finance.yahoo.com/q/h?s=OVIT.OB+Headlines

 

 

-----------------------

 

 

 

AdnaGen

http://www.adnagen.com/

 

News from AdnaGen site, which is majority owned by OVIT

http://www.adnagen.com/HTML_Dateien/e_news_news.htm

 

OVIT used to own 78% of the issued and outstanding shares of AdnaGen*

 

* On November 2, 2010, OncoVista Innovative Therapies, Inc. (the "Company") entered into a Stock Purchase Agreement with Alere Holdings Bermuda Limited Canon's Court ("Alere Holdings"), whereby the Company sold all of its shares, representing approximately 78.01% of the total issued and outstanding shares, of its majority-owned German operating subsidiary AdnaGen AG ("AdnaGen").   Under the terms of the Stock Purchase Agreement, the Company and the other AdnaGen shareholders agreed to sell their respective shares of AdnaGen, and all AdnaGen related business assets, to Alere Holdings in consideration of: (i) a $10,000,000 up-front;  (ii) $10,000,000 in potential milestone payments contingent upon the achievement of various balance sheet objectives within 24 months; and (iii) up to $63,000,000 in potential milestone payments contingent upon the achievement of various clinical, regulatory and sales objectives within 36 months (collectively, the "Consideration").  The Company is entitled to receive its pro rata portion of approximately 78.01% of all Consideration.http://www.sec.gov/Archives/edgar/data/1094847/000114420410057309/v200923_8k.htm

 

----------------------

  

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001094847&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

Share Structure:

Authorized Shares

147,397,390 as of September 30, 2011

 

Outstanding Shares

21,370,725 as of September 30, 2011

 

Investor Relations:

Aimee Boutcher

973-239-2878

aboutcher@aol.com

 

 

 


 

 


 

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Also, keep in mind that moderators may or may not have a position in said stock. 

Being a moderator isn't a sign of endorsement. In fact, the current Mod thinks that the founders of TI, the LLC company behind OVIT (and NNAN and BIPH), are practising crooks.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp

 

OVIT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#310   I sold long ago for a loss. They gi197845 07/27/17 12:46:54 PM
#309   Look at today's SP. It's a brain dead Batermere 07/27/17 12:34:02 PM
#308   Ok, I would have thought that OVIT would gi197845 07/27/17 12:17:44 PM
#307   I don't really know. There have been 128K Batermere 07/26/17 03:59:20 PM
#306   Maybe, but why is OVIT being bought routinely gi197845 07/26/17 02:56:58 PM
#305   Huh? I'm calling BS. Batermere 07/25/17 08:37:05 PM
#304   2Q filed on 7/22/17, OVIT back in business!!! gi197845 07/25/17 08:35:38 PM
#303   I seriously doubt its institutional buying. Just some biotech2 07/18/17 05:23:22 PM
#302   Yep, gi. I still have all of my Batermere 07/18/17 11:49:03 AM
#301   Hmmm...Who's buying? I sold all of my OVIT gi197845 07/18/17 11:40:19 AM
#300   Do Jewish folks beleive in Lazarus ? i dunno biotech2 07/18/17 11:40:06 AM
#299   LAZARUS is alive and well!!!! Batermere 07/18/17 10:10:01 AM
#298   2 day rally. start of something ? biotech2 07/17/17 01:46:20 PM
#297   If somehow OVIT becomes a viable Biotech operation Batermere 07/16/17 05:25:19 PM
#296   being dormant does not prevent you from being biotech2 07/16/17 04:17:05 PM
#295   Boitech2, thanks for the reply, but maybe Dr.Weis gi197845 07/16/17 02:19:49 PM
#294   there is NO time limit on dormancy. Weis biotech2 07/16/17 09:38:39 AM
#292   Batermere or anyone, how long can Ovit stay gi197845 06/27/17 12:05:59 PM
#291   Terrible OVIT nightmare lastnight!!! All of the sudden, gi197845 06/15/17 12:18:36 PM
#290   The fun starts next Spring, thanks Dr.Weis! gi197845 06/05/17 05:51:14 PM
#289   SOMEONE SOLD FOR TAX LOSS IN MAY ??? weird biotech2 06/01/17 05:36:05 PM
#288   this stock looks dead, that's usually when something biotech2 05/19/17 09:32:56 AM
#287   Wow, 62K shares. That's a whole $620. Lol. Batermere 05/02/17 11:31:27 AM
#286   SOME ONE BOUGHT SOME SHARES. biotech2 05/02/17 10:13:19 AM
#285   The fun starts this Winter...Not!!! gi197845 04/18/17 08:48:30 PM
#284   .008. Thanks, Dr Weiss. CON MAN of the Batermere 04/18/17 10:43:48 AM
#283   The fun starts this Fall...Not!!! gi197845 04/08/17 12:11:55 PM
#282   Maybe he didn't have the motivation to get Batermere 03/30/17 01:13:17 PM
#281   why would he want to make his 5 biotech2 03/30/17 11:16:02 AM
#280   Because we all got conned by the Founder Batermere 03/29/17 10:25:34 PM
#279   Interesting read on leukemia tests, wonder why biotech2 03/29/17 10:10:16 PM
#278   The fun starts this summer...NOT! gi197845 03/26/17 01:38:33 PM
#277   Salexander1, the mentioning of Onco Vista in the gi197845 03/26/17 01:37:43 PM
#276   OncoVista mentioned in this Dec. 2016 article related Salexander1 03/19/17 07:42:40 PM
#275   OVI-123 wasn't given, it was taken, because OVIT gi197845 03/19/17 11:53:21 AM
#274   Correction: Rainforest...not Rainwater Salexander1 03/19/17 09:39:53 AM
#273   Like to see Rainwater go public and do Salexander1 03/19/17 09:38:56 AM
#272   It wasn't taken. Those guys are San Antonio LSGroup 03/18/17 09:14:56 PM
#271   That's just another nail in OVITs coffin. OVIT gi197845 03/18/17 08:45:11 PM
#270   It wasn't sold to Rainforest, it was taken gi197845 03/18/17 08:42:36 PM
#269   I believe it was Rainforest Pharmacal and no clue. LSGroup 03/14/17 08:30:44 PM
#268   What happened with the drug that was sold Salexander1 03/14/17 04:40:12 PM
#267   FWIW Oncovista still going after ex CFO J LSGroup 03/14/17 03:35:40 PM
#266   biotech2.... care to elaborate? Batermere 03/10/17 08:56:06 PM
#265   looks like OVIT has started, EGBB soon biotech2 03/10/17 08:52:55 PM
#264   interesting drug, could be worth a lot of money biotech2 03/10/17 08:13:28 PM
#263   http://en.pharmacodia.com/web/drug/1_6750.html#onlineretailersBasic Does anyb Salexander1 03/10/17 10:47:40 AM
#262   It could easily go Bankrupt and/or just close Salexander1 03/10/17 10:13:58 AM
#261   Haha. True dat. We are scraping the bottom. Batermere 03/09/17 09:57:15 PM
#260   it can't go any lower, LOL biotech2 03/09/17 09:27:49 PM
PostSubject